Dianthus Therapeutics, Inc. (DNTH)
(Delayed Data from NSDQ)
$26.01 USD
+1.72 (7.08%)
Updated May 13, 2024 04:00 PM ET
After-Market: $26.05 +0.04 (0.15%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | -25.58% |
ABR | 1.17 |
Earnings ESP
|
-7.27% |
---|---|
Current Year | -2.29 |
Next Year | -2.48 |
EPS (TTM) | -5.83 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.63M | 0.63M | 2.63M | 2.61M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 0.93M | 0.93M | 3.65M | 4.01M |
Low Estimate | 0.46M | 0.46M | 2.00M | 1.83M |
Year ago Sales | 0.00M | 0.92M | 2.83M | 2.63M |
Year over Year Growth Est. | NA | -31.52% | -6.83% | -0.76% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.60 | -2.29 | -2.48 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.43 | -0.47 | -1.79 | -2.09 |
High Estimate | -0.43 | -0.47 | -1.79 | -2.09 |
Low Estimate | -0.85 | -0.92 | -3.29 | -3.19 |
Year ago EPS | -0.80 | -3.78 | -8.45 | -2.29 |
Year over Year Growth Est. | 31.25% | 84.13% | 72.90% | -8.41% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | 3 | 3 | 3 | 3 |
Down Last 30 Days | 3 | 3 | 3 | 3 |
Down Last 60 Days | 1 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.60 | -2.29 | -2.48 |
7 Days Ago | -0.44 | -0.50 | -1.92 | -2.12 |
30 Days Ago | -0.44 | -0.50 | -1.92 | -2.12 |
60 Days Ago | -0.81 | -0.87 | -3.65 | -3.25 |
90 Days Ago | -0.81 | -0.86 | -3.73 | -3.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.50 | -1.92 | -2.12 |
Zacks Consensus Estimate | -0.44 | -0.50 | -1.92 | -2.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.71 | -3.78 | -0.80 | NA |
Estimate | -0.43 | -1.11 | -0.51 | -3.04 | NA |
Difference | -0.11 | 0.40 | -3.27 | 2.24 | -0.19 |
Surprise | -25.58% | 36.04% | -641.18% | 73.68% | -139.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more